® Consulta de Marcas Base do INPI · pesquisa e monitoramento

CRISPR-Q

Registro de marca em vigor (Madri)

Marca Nominativa depositada no INPI em 18/06/2021 por Qiagen GmbH, processo nº 501628229, nas classes 01, 05. Registro em vigor até 18/06/2031.

Número do processo501628229
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito18/06/2021
Data da concessão19/09/2023
Vigência até18/06/2031
TitularQiagen GmbH
CNPJ/CPF do titular
UF · País— · DE

Classes e especificação

Classe 01 — Produtos químicos

Chemical, biochemical and biotechnological diagnostic preparations for scientific use, non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes.;

Classe 05 — Farmacêuticos e saúde

Diagnostic preparations for medical and veterinary purposes, namely diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501628229 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

3 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 19/09/2023 Concessão de registro em designação código IPAS770 · RPI 2750
  2. 04/10/2022 Deferimento de designação código IPAS768 · RPI 2700
  3. 17/05/2022 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2680

Outras marcas de Qiagen GmbH